Metavia INC DEF 14A proxy statements

MetaVia Inc. is holding its 2026 Annual Meeting of Stockholders on June 8, 2026, to vote on director elections, auditor ratification, a reverse stock split, and equity plan amendments.

MetaVia Inc. is calling for its 2025 Annual Meeting of Stockholders to vote on critical proposals including a reverse stock split to meet Nasdaq listing requirements and the approval of shares issued in a recent private placement to fund ongoing operations.

NeuroBo Pharmaceuticals is holding a special meeting on September 18, 2024, to seek stockholder approval for the issuance of shares related to warrants issued in private placements.

NeuroBo Pharmaceuticals announces its 2024 annual meeting of stockholders to be held virtually on June 7, 2024, featuring proposals for director elections, auditor ratification, and equity incentive plan amendment.